Skip to main content

Alpha Thalassemia Major clinical trials at UCSF

2 research studies open to eligible people

Alpha thalassemia major is a serious blood disorder where the body makes less hemoglobin than normal. UCSF is running a study to check the safety of a new stem cell transplant treatment. Another study is collecting data from patients worldwide to understand the disease better.

Showing trials for

Our lead scientists for Alpha Thalassemia Major research studies include .